MarkHerz, a Company Specializing in Gene Delivery Therapy, Signed an MOU with Haiam Bio to Develop AAV Gene Therapy for the Treatment of Cardiovascular Diseases
MarkHerz (CEO Lee Seung-min), a company specializing in gene delivery systems, signed a memorandum of understanding (MOU) with bio-venture company ...
